News

We provide the latest news
from the world of economics and finance

Back
30 January
Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say

Cigna (CI) reported $65.68 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 28.4%. EPS of $6.64 for the same period compares to $6.79 a year ago.

The reported revenue represents a surprise of +3.85% over the Zacks Consensus Estimate of $63.25 billion. With the consensus EPS estimate being $7.83, the EPS surprise was -15.20%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Cigna performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Medical Care Ratio - Cigna Healthcare: 87.9% versus 84.5% estimated by eight analysts on average.
  • Medical Customers - Total: 19.15 million compared to the 19.17 million average estimate based on five analysts.
  • Total Medical Customers - Medicare Part D: 2.57 million versus the three-analyst average estimate of 2.56 million.
  • Medical Customers - U.S. Healthcare administrative services: 13.65 million versus the three-analyst average estimate of 13.63 million.
  • Revenues- Fees and Other: $3.93 billion versus the six-analyst average estimate of $3.73 billion. The reported number represents a year-over-year change of +29%.
  • Revenues- Premiums: $11.50 billion versus the six-analyst average estimate of $11.45 billion. The reported number represents a year-over-year change of +2.9%.
  • Revenues- Pharmacy: $49.94 billion versus the six-analyst average estimate of $48.20 billion. The reported number represents a year-over-year change of +36.4%.
  • Revenues- Evernorth Health Services: $53.74 billion compared to the $51.10 billion average estimate based on six analysts. The reported number represents a change of +32.6% year over year.
  • Revenues- Cigna Healthcare- Premiums: $11.38 billion versus the six-analyst average estimate of $11.27 billion. The reported number represents a year-over-year change of +2.5%.
  • Revenues- Net investment income: $277 million versus $254.43 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -4.5% change.
  • Revenues- Cigna Healthcare: $13.30 billion versus $13.37 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +2.5% change.
  • Revenues- Evernorth Health Services- Pharmacy: $50.75 billion versus $48.74 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +34.4% change.

View all Key Company Metrics for Cigna here>>>

Shares of Cigna have returned +9.8% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cigna Group (CI) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

х
Risk warning: Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.
Contact usCollapse